BRAF and cancer: Since the majority of our MSI+ cancers (23/35) and all our SSA samples also carry a BRAFV600E mutation we suggest it is likely that rs1800734 influences the acquisition of methylation via the BRAF/MAFG pathway described by Feng et al. 4.